Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil

This study reports the first case of an innovative drop-on-powder (DoP) three-dimensional (3D) printing technology to produce oral tablets (diameters of 10 mm and 13 mm) loaded with an anticancer model drug, 5-fluorouracil (FLU). For this study, a composition of the powder carrier containing CaSO<...

Full description

Bibliographic Details
Main Authors: Kejing Shi, Deck K. Tan, Ali Nokhodchi, Mohammed Maniruzzaman
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/11/4/150
id doaj-cb61695fc49e4f86af3852a208e47002
record_format Article
spelling doaj-cb61695fc49e4f86af3852a208e470022020-11-25T00:35:05ZengMDPI AGPharmaceutics1999-49232019-04-0111415010.3390/pharmaceutics11040150pharmaceutics11040150Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-FluorouracilKejing Shi0Deck K. Tan1Ali Nokhodchi2Mohammed Maniruzzaman3School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, UKSchool of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, UKSchool of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, UKSchool of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, UKThis study reports the first case of an innovative drop-on-powder (DoP) three-dimensional (3D) printing technology to produce oral tablets (diameters of 10 mm and 13 mm) loaded with an anticancer model drug, 5-fluorouracil (FLU). For this study, a composition of the powder carrier containing CaSO<sub>4</sub> hydrates, vinyl polymer, and carbohydrate was used as the matrix former, whereas 2-pyrrolidone with a viscosity like water was used as a binding liquid or inkjet ink. All tablets were printed using a commercial ZCorp 3D printer with modification. The resultant tablets were subject to coating with various polymeric solutions containing the drug. The composition of the polymeric solutions was adjusted at drug: polymer(s) 1:1 (<i>w</i>/<i>w</i>) ratio. Either Soluplus<sup>&#174;</sup> (SOL) alone or in combination with polyethylene glycol (PEG) was used to develop the coating solution of 2.5% (<i>w</i>/<i>v</i>) concentration. The particle size analysis, flow test, and particle morphology studies revealed mono-modal narrow size distribution, good flow properties, and porous loosely bound texture (of the tablets), respectively. Moreover, the advanced application of the fluorescence microscopy showed a homogenous distribution of the drug throughout the surface of the 3D printed tablets. The <i>in vitro</i> dissolution studies showed that the tablet compositions, dimensions, and the coating solution compositions influenced the release of the drug from the tablets. It can be concluded that our innovative DoP 3D printing technology can be used to fabricate personalized dosage forms containing optimized drug content with high accuracy and shape fidelity. This is particularly suitable for those drugs that are highly unstable in thermal processing and cannot withstand the heat treatment, such as in fused deposition modeling (FDM) 3D printing.https://www.mdpi.com/1999-4923/11/4/1503D printingdrop-on-powderpowder-based 3D printingpersonalized medicine5-fluorouracilSoluplus
collection DOAJ
language English
format Article
sources DOAJ
author Kejing Shi
Deck K. Tan
Ali Nokhodchi
Mohammed Maniruzzaman
spellingShingle Kejing Shi
Deck K. Tan
Ali Nokhodchi
Mohammed Maniruzzaman
Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil
Pharmaceutics
3D printing
drop-on-powder
powder-based 3D printing
personalized medicine
5-fluorouracil
Soluplus
author_facet Kejing Shi
Deck K. Tan
Ali Nokhodchi
Mohammed Maniruzzaman
author_sort Kejing Shi
title Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil
title_short Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil
title_full Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil
title_fullStr Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil
title_full_unstemmed Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil
title_sort drop-on-powder 3d printing of tablets with an anti-cancer drug, 5-fluorouracil
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2019-04-01
description This study reports the first case of an innovative drop-on-powder (DoP) three-dimensional (3D) printing technology to produce oral tablets (diameters of 10 mm and 13 mm) loaded with an anticancer model drug, 5-fluorouracil (FLU). For this study, a composition of the powder carrier containing CaSO<sub>4</sub> hydrates, vinyl polymer, and carbohydrate was used as the matrix former, whereas 2-pyrrolidone with a viscosity like water was used as a binding liquid or inkjet ink. All tablets were printed using a commercial ZCorp 3D printer with modification. The resultant tablets were subject to coating with various polymeric solutions containing the drug. The composition of the polymeric solutions was adjusted at drug: polymer(s) 1:1 (<i>w</i>/<i>w</i>) ratio. Either Soluplus<sup>&#174;</sup> (SOL) alone or in combination with polyethylene glycol (PEG) was used to develop the coating solution of 2.5% (<i>w</i>/<i>v</i>) concentration. The particle size analysis, flow test, and particle morphology studies revealed mono-modal narrow size distribution, good flow properties, and porous loosely bound texture (of the tablets), respectively. Moreover, the advanced application of the fluorescence microscopy showed a homogenous distribution of the drug throughout the surface of the 3D printed tablets. The <i>in vitro</i> dissolution studies showed that the tablet compositions, dimensions, and the coating solution compositions influenced the release of the drug from the tablets. It can be concluded that our innovative DoP 3D printing technology can be used to fabricate personalized dosage forms containing optimized drug content with high accuracy and shape fidelity. This is particularly suitable for those drugs that are highly unstable in thermal processing and cannot withstand the heat treatment, such as in fused deposition modeling (FDM) 3D printing.
topic 3D printing
drop-on-powder
powder-based 3D printing
personalized medicine
5-fluorouracil
Soluplus
url https://www.mdpi.com/1999-4923/11/4/150
work_keys_str_mv AT kejingshi droponpowder3dprintingoftabletswithananticancerdrug5fluorouracil
AT deckktan droponpowder3dprintingoftabletswithananticancerdrug5fluorouracil
AT alinokhodchi droponpowder3dprintingoftabletswithananticancerdrug5fluorouracil
AT mohammedmaniruzzaman droponpowder3dprintingoftabletswithananticancerdrug5fluorouracil
_version_ 1725310437434589184